Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

[Daily subcutaneous injection of teriparatide : the progress and current issues].

Yano S, Sugimoto T.

Clin Calcium. 2014 Jan;24(1):35-43. doi: CliCa14013543. Review. Japanese.

PMID:
24369278
[PubMed - indexed for MEDLINE]
2.

[Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].

Sowa H, Hamaya E, Yamamoto T.

Clin Calcium. 2011 Jan;21(1):9-16. doi: CliCa1101916. Review. Japanese.

PMID:
21187589
[PubMed - indexed for MEDLINE]
3.

[Once-weekly teriparatide treatment on osteoporosis].

Nakano T.

Clin Calcium. 2014 Jan;24(1):100-5. doi: CliCa1401100105. Review. Japanese.

PMID:
24369286
[PubMed - indexed for MEDLINE]
4.

Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study.

Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Takaso M, Ozawa T, Takahashi K, Toyone T.

Spine (Phila Pa 1976). 2012 Nov 1;37(23):E1464-8. doi: 10.1097/BRS.0b013e31826ca2a8.

PMID:
22872218
[PubMed - indexed for MEDLINE]
5.

Indications to teriparatide treatment in patients with osteoporosis.

Rizzoli R, Kraenzlin M, Krieg MA, Mellinghoff HU, Lamy O, Lippuner K.

Swiss Med Wkly. 2011 Nov 7;141:w13297. doi: 10.4414/smw.2011.13297.

PMID:
22057669
[PubMed - indexed for MEDLINE]
Free Article
6.

Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk.

Nakamura T, Sugimoto T, Nakano T, Kishimoto H, Ito M, Fukunaga M, Hagino H, Sone T, Yoshikawa H, Nishizawa Y, Fujita T, Shiraki M.

J Clin Endocrinol Metab. 2012 Sep;97(9):3097-106. doi: 10.1210/jc.2011-3479. Epub 2012 Jun 20.

PMID:
22723322
[PubMed - indexed for MEDLINE]
7.

[Therapeutic agents for disorders of bone and calcium metabolism--Teriparatide, parathyroid hormone (1-34) as a daily subcutaneous injection].

Hashimoto Y, Wakayama N, Miyauchi A.

Clin Calcium. 2007 Jan;17(1):48-55. Review. Japanese.

PMID:
17211093
[PubMed - indexed for MEDLINE]
8.

Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.

Cosman F, Eriksen EF, Recknor C, Miller PD, GuaƱabens N, Kasperk C, Papanastasiou P, Readie A, Rao H, Gasser JA, Bucci-Rechtweg C, Boonen S.

J Bone Miner Res. 2011 Mar;26(3):503-11. doi: 10.1002/jbmr.238.

PMID:
20814967
[PubMed - indexed for MEDLINE]
9.

Teriparatide in the treatment of osteoporosis.

Stroup J, Kane MP, Abu-Baker AM.

Am J Health Syst Pharm. 2008 Mar 15;65(6):532-9. doi: 10.2146/ajhp070171. Review.

PMID:
18319498
[PubMed - indexed for MEDLINE]
10.

[Evidence in the treatment of osteoporosis using weekly teriparatide injections].

Nakamura Y.

Clin Calcium. 2012 Mar;22(3):407-13. doi: CliCa1203407413. Review. Japanese.

PMID:
22370308
[PubMed - indexed for MEDLINE]
12.

Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.

Anastasilakis AD, Polyzos SA, Avramidis A, Papatheodorou A, Terpos E.

Horm Metab Res. 2009 Jul;41(7):559-62. doi: 10.1055/s-0029-1192035. Epub 2009 Feb 9.

PMID:
19204890
[PubMed - indexed for MEDLINE]
13.

[Evidence for osteoporosis treatment using PTH (1-34) daily subcutaneous injection].

Yamamoto T, Hamaya E, Sowa H.

Clin Calcium. 2012 Mar;22(3):399-406. doi: CliCa1203399406. Review. Japanese.

PMID:
22370307
[PubMed - indexed for MEDLINE]
14.

Reduced risk of back pain following teriparatide treatment: a meta-analysis.

Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.

Osteoporos Int. 2006 Feb;17(2):273-80. Epub 2005 Sep 2. Review.

PMID:
16142502
[PubMed - indexed for MEDLINE]
15.

[Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis].

Marumo K, Saito M.

Nihon Rinsho. 2011 Jul;69(7):1264-9. Japanese.

PMID:
21774369
[PubMed - indexed for MEDLINE]
16.

[Effects of parathyroid hormone (teriparatide) on bone quality in osteoporosis].

Saito M, Marumo K.

Clin Calcium. 2012 Mar;22(3):343-55. doi: CliCa1203343355. Review. Japanese.

PMID:
22370301
[PubMed - indexed for MEDLINE]
17.

Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

Brixen KT, Christensen PM, Ejersted C, Langdahl BL.

Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70. Review.

PMID:
15228497
[PubMed - indexed for MEDLINE]
18.

Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.

Bilezikian JP.

Curr Osteoporos Rep. 2008 Mar;6(1):24-30. Review.

PMID:
18430397
[PubMed - indexed for MEDLINE]
19.

[Treatment of osteoporosis with PTH].

Takeuchi Y.

Clin Calcium. 2014 Jun;24(6):893-902. doi: CliCa1406893902. Review. Japanese.

PMID:
24870841
[PubMed - indexed for MEDLINE]
20.

[Monitoring bone turnover markers during treatment with the anabolic agent teriparatide; in particular, treatment using daily and weekly subucutaneous injections].

Miyauchi A.

Clin Calcium. 2012 Mar;22(3):387-98. doi: CliCa1203387398. Review. Japanese.

PMID:
22370306
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk